Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Disaggregation Of Revenue [Abstract]

Summary of information about disaggregated revenue by product mix

The following table provides information about disaggregated revenue by product mix and service (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Product revenue:
ANNOVERA	$	10,415	$	11,807	$	37,196	$	30,112
IMVEXXY		6,947		8,016		20,583		24,866
BIJUVA		2,663		3,298		7,877		7,899
Prescription vitamin		892		1,335		2,671		4,162
Product revenue, net		20,917		24,456		68,327		67,039
License and service		-		950		484		1,234
Total revenue, net	$	20,917	$	25,406	$	68,811	$	68,273